Effects of danazol on mineral homeostasis in normal postmenopausal women: preliminary communication.
The effects of danazol on calcium homeostasis in normal postmenopausal women was examined in a 14-day study utilizing a dosage of 800 mg per day. Danazol caused significant falls in plasma ionized calcium and in the fasting urinary calcium/creatinine ratio, indicating inhibition of bone resorption. Retention of phosphate was also observed as expected with this anabolic agent. The plasma total alkaline phosphatase was also depressed by the drug, which had no effect on hepatocellular function as measured by plasma AST. Certain effects induced by treatment with danazol were still apparent two weeks after cessation of treatment. The drug was well tolerated and androgenic side effects were not seen. It is suggested that the minimal dose regimen of danazol which exerts a calcium-sharing effect should be identified, and that this regimen should be considered for use in a prospective study of the effects of danazol on bone mineral content in the postmenopause.
Department of Obstetrics & Gynaecology, University of Leeds.
D W
DW
Purdie
A
A
Hay
S K
SK
Abbas
D001862:Bone Resorption / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D003613:Danazol / Q000494:pharmacology*; D005260:Female; D006706:Homeostasis / Q000187:drug effects*; D006801:Humans; D008593:Menopause / Q000378:metabolism*; D008875:Middle Aged; D010710:Phosphates / Q000378:metabolism; D011245:Pregnadienes / Q000494:pharmacology*
D010710:Phosphates; D011245:Pregnadienes; D003613:Danazol; D002118:Calcium